The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Abstract
Metabolic syndrome (MS) is a chronic non‐infective syndrome characterised clinically by a set of vascular risk factors that include insulin resistance, hypertension, abdominal obesity, impaired glucose metabolism, and dyslipidaemia. These risk factors are due to a pro‐inflammatory state, oxidative stress, haemodynamic dysfunction, and ischaemia, which overlap in ‘dysmetabolic’ patients. This review aimed to evaluate the relationship between the traditional components of MS with cardiovascular disease (CVD), inflammation, and oxidative stress. MEDLINE‐PubMed, EMBASE, and Cochrane databases were searched. Chronic low‐grade inflammatory states and metaflammation are often accompanied by metabolic changes directly related to CVD incidence, such as diabetes mellitus, hypertension, and obesity. Moreover, the metaflammation is characterised by an increase in the serum concentration of pro‐inflammatory cytokines, mainly interleukin‐1 β (IL‐1β), IL‐6, and tumour necrosis factor‐α (TNF‐α), originating from the chronically inflamed adipose tissue and associated with oxidative stress. The increase of reactive oxygen species overloads the antioxidant systems causing post‐translational alterations of proteins, lipids, and DNA leading to oxidative stress. Hyperglycaemia contributes to the increase in oxidative stress and the production of advanced glycosylation end products (AGEs) which are related to cellular and molecular dysfunction. Oxidative stress and inflammation are associated with cellular senescence and CVD. CVD should not be seen only as being triggered by classical MS risk factors. Atherosclerosis is a multifactorial pathological process with several triggering and aetiopathogenic mechanisms. Its medium and long‐term repercussions, however, invariably constitute a significant cause of morbidity and mortality. Implementing preventive and therapeutic measures against oxy‐reductive imbalances and metaflammation states has unquestionable potential for favourable clinical outcomes in cardiovascular medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,266
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Senoner, T., & Dichtl, W. (2019) · Nutrients · doi:10.3390/nu11092090 · Cited by 868
Ridker, P. M., Devalaraja, M., Baeres, F. M. M., Engelmann, M. D. M., Hovingh, G. K., Ivkovic, M., Lo, L., Kling, D., Pergola, P., Raj, D., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00520-1 · Cited by 737
Atherosclerosis and inflammation: overview and updates
Geovanini, G. R., & Libby, P. (2018) · Clinical Science · doi:10.1042/cs20180306 · Cited by 703
Pharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671 · cited 2×
“Triggering: in response to the second contact of a PRR with DAMPs or PAMPs, there is the oligomerisation of NLRP3 complexes and consequent activation of caspase‐1, the enzyme responsible for the conversion of pro‐IL‐1β and pro‐IL‐18 precursors into their respective effector molecules.(50)”
BackgroundPhysical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome
Myers, J., Kokkinos, P., & Nyelin, E. (2019) · Nutrients · doi:10.3390/nu11071652 · Cited by 630
Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8563845 · Cited by 621
Psychological Stress, Inflammation, and Coronary Heart Disease
Wirtz, P. H., & von Känel, R. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0919-x · Cited by 539
Role of pyroptosis in cardiovascular disease
Zhaolin, Z., Guohua, L., Shiyuan, W., & Zuo, W. (2019) · Cell Proliferation · doi:10.1111/cpr.12563 · Cited by 493
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
Katakami, N. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17014 · Cited by 472
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Raggi, P., Genest, J., Giles, J. T., Rayner, K. J., Dwivedi, G., Beanlands, R. S., & Gupta, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.014 · Cited by 433
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Advanced glycation end products in the pathogenesis of chronic kidney disease
Rabbani, N., & Thornalley, P. J. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.034 · Cited by 387
Ultra-processed Foods and Cardiovascular Diseases: Potential Mechanisms of Action
Juul, F., Vaidean, G., & Parekh, N. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab049 · Cited by 374
Fishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595371 · Cited by 289
Daiber, A., Di Lisa, F., Oelze, M., Kröller‐Schön, S., Steven, S., Schulz, E., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13403 · Cited by 269
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Liu, D., Zeng, X., Li, X., Mehta, J. L., & Wang, X. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-017-0663-9 · Cited by 258
Papaconstantinou, J. (2019) · Cells · doi:10.3390/cells8111383 · Cited by 258
Monounsaturated Fatty Acids in Obesity-Related Inflammation
Ravaut, G., Légiot, A., Bergeron, K.-F., & Mounier, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010330 · Cited by 249
Structure, function, and regulation of mitofusin‐2 in health and disease
Chandhok, G., Lazarou, M., & Neumann, B. (2018) · Biological Reviews · doi:10.1111/brv.12378 · Cited by 247
Inflammation, Frailty and Cardiovascular Disease
Soysal, P., Arik, F., Smith, L., Jackson, S. E., & Isik, A. T. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-33330-0_7 · Cited by 244
A systematic review of p53 regulation of oxidative stress in skeletal muscle
Beyfuss, K., & Hood, D. A. (2018) · Redox Report · doi:10.1080/13510002.2017.1416773 · Cited by 239
Rangel-Huerta, O. D., Pastor-Villaescusa, B., & Gil, A. (2019) · Metabolomics · doi:10.1007/s11306-019-1553-y · Cited by 221
Oxidative stress and cardiovascular disease: new insights
Pignatelli, P., Menichelli, D., Pastori, D., & Violi, F. (2018) · Kardiologia Polska · doi:10.5603/kp.a2018.0071 · Cited by 211
Mitochondrial disease and endocrine dysfunction
Chow, J., Rahman, J., Achermann, J. C., Dattani, M. T., & Rahman, S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.151 · Cited by 206
Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
Sas, K., Szabó, E., & Vécsei, L. (2018) · Molecules · doi:10.3390/molecules23010191 · Cited by 198
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194 · cited 1×
“interact with circulating proteins, amplifying the synthesis of these substances.(82) This class of compounds prominent representatives is glyoxal, methylglyoxal, 3‐deoxyglucosone, glycolaldehyde, and glyceraldehyde.”
BackgroundOxidative Stress and Hypertensive Diseases
Loperena, R., & Harrison, D. G. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.004 · Cited by 189
NLRP3: A Novel Mediator in Cardiovascular Disease
Zhou, W., Chen, C., Chen, Z., Liu, L., Jiang, J., Wu, Z., Zhao, M., & Chen, Y. (2018) · Journal of Immunology Research · doi:10.1155/2018/5702103 · Cited by 172
End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes
Dai, L., Golembiewska, E., Lindholm, B., & Stenvinkel, P. (2017) · Contributions to Nephrology · doi:10.1159/000479254 · Cited by 170
Oxidative Stress in Ischemic Heart Disease
Kibel, A., Lukinac, A. M., Đambić, V., Jurić, I., & Selthofer-Relatić, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6627144 · Cited by 160
Liu, C. H., Abrams, N., Carrick, D. M., Chander, P., Dwyer, J. T., Hamlet, M. R. J., Macchiarini, F., PrabhuDas, M., Shen, G. L., Tandon, P., et al. (2017) · Nature Immunology · doi:10.1038/ni.3828 · Cited by 145
Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health
Nocella, C., Cammisotto, V., Fianchini, L., D’Amico, A., Novo, M., Castellani, V., Stefanini, L., Violi, F., & Carnevale, R. (2017) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530317666171114121533 · Cited by 143
Serreli, G., & Deiana, M. (2020) · Cells · doi:10.3390/cells9020478 · Cited by 142
Oxidative Stress Biomarkers, Nut-Related Antioxidants, and Cardiovascular Disease
dos Santos, J. L., de Quadros, A. S., Weschenfelder, C., Garofallo, S. B., & Marcadenti, A. (2020) · Nutrients · doi:10.3390/nu12030682 · Cited by 140
Impact of advanced glycation end products (AGEs) signaling in coronary artery disease
Kosmopoulos, M., Drekolias, D., Zavras, P. D., Piperi, C., & Papavassiliou, A. G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.01.006 · Cited by 136
Schirrmacher, V. (2020) · Biomedicines · doi:10.3390/biomedicines8110526 · Cited by 133
Antioxidant therapy for management of oxidative stress induced hypertension
Ahmad, K. A., Yuan, D. Y., Nawaz, W., Hong, Z., Zhuo, C. X., Talal, B., Taleb, A., Mais, E., & Qi-long, D. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1322205 · Cited by 122
Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
Noce, A., Lauro, M. D., Daniele, F. D., Zaitseva, A. P., Marrone, G., Borboni, P., & Daniele, N. D. (2021) · Nutrients · doi:10.3390/nu13020630 · Cited by 120
The role of interleukin-6 in glucose homeostasis and lipid metabolism
Lehrskov, L. L., & Christensen, R. H. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00747-2 · Cited by 114
Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review
Wu, M., Liu, L., Xing, Y., Yang, S., Li, H., & Cao, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00118 · Cited by 110
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases
Parsanathan, R., & Jain, S. K. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0073 · Cited by 98
The role of stress kinases in metabolic disease
Nikolić, I., Leiva, M., & Sabio, G. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00418-5 · Cited by 93
Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?
Liakopoulos, V., Roumeliotis, S. K., Bozikas, A., Eleftheriadis, T., & Dounousi, E. C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9109473 · Cited by 89
Vitale, M., Vaccaro, O., Masulli, M., Bonora, E., Prato, S. D., Giorda, C. B., Nicolucci, A., Squatrito, S., Auciello, S., Babini, A. C., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.002 · Cited by 81
Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis
Xu, H., Li, C., Mozziconacci, O., Zhu, R., Xu, Y., Tang, Y., Chen, R., Huang, Y. L., Holzbeierlein, J. M., Schöneich, C., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.019 · Cited by 80
Deluyker, D., Evens, L., & Bito, V. (2017) · Amino Acids · doi:10.1007/s00726-017-2464-8 · Cited by 77
Liu, Z., Yang, H., Chen, S., Cai, J., & Huang, Z. (2018) · Journal of Public Health · doi:10.1093/pubmed/fdy121 · Cited by 76
Metabolic syndrome and liver-related events: a systematic review and meta-analysis
Ren, H., Wang, J., Gao, Y., Yang, F., & Huang, W. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0366-3 · Cited by 76
Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model
Aksentijevich, M., Lateef, S. S., Anzenberg, P., Dey, A. K., & Mehta, N. N. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.11.001 · Cited by 76
Sumida, Y., Yoneda, M., Tokushige, K., Kawanaka, M., Fujii, H., Yoneda, M., Imajo, K., Takahashi, H., Eguchi, Y., Ono, M., et al. (2021) · Life · doi:10.3390/life11020143 · Cited by 75
Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells
Chistiakov, D. A., Kashirskikh, D. A., Khotina, V. A., Grechko, A. V., & Orekhov, A. N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111798 · Cited by 74
Liu, Y., Wu, Q., Xia, Y., Zhang, J., Jiang, Y., Chang, Q., & Zhao, Y. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.003 · Cited by 72
MYERS, J. N., Kokkinos, P. F., Arena, R. A., & LaMonte, M. J. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.11.003 · Cited by 72
Role of macrophages in the endocrine system
Rehman, A., Pacher, P., & Haskó, G. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.12.001 · Cited by 71
Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer
Toya, T., Sara, J. D. S., Corban, M., Taher, R., Godo, S., Herrmann, J., Lerman, L. O., & Lerman, A. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319884246 · Cited by 71
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 67
Molecular insights of NADPH oxidases and its pathological consequences
Waghela, B. N., Vaidya, F. U., Agrawal, Y., Santra, M. K., Mishra, V., & Pathak, C. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3589 · Cited by 63
Poston, R. N. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000172 · Cited by 62
Zhang, N., Zhang, Y., Wu, B., You, S., & Sun, Y. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101419 · Cited by 59
Sullivan, S. M., Hammadah, M., Wilmot, K. A., Ramadan, R., Pearce, B. D., Shah, A. J., Kaseer, B., Gafeer, M. M., Lima, B. B., Kim, J. H., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010329 · Cited by 58
Garay‐Sevilla, M. E., Beeri, M. S., de la Maza, M. P., Armando Rojas, R., Salazar‐Villanea, S., & Uribarri, J. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000104 · Cited by 55
Piazzolla, G., Candigliota, M., Fanelli, M., Castrovilli, A., Berardi, E., Antonica, G., Battaglia, S., Solfrizzi, V., Sabbà, C., & Tortorella, C. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0484-0 · Cited by 54
Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome
Wittwer, J. A., & Bradley, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612496 · Cited by 52
Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review
Zulhendri, F., Ravalia, M., Kripal, K., Chandrasekaran, K., Fearnley, J., & Perera, C. O. (2021) · Antioxidants · doi:10.3390/antiox10030348 · Cited by 52
Khan, M. S., Ikram, M. A., Park, T. J., & Kim, M. O. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4051207 · Cited by 48
Zhao, L., Shu, X., Li, H., Zhang, W., Gao, J., Sun, J., Zheng, W., & Xiang, Y. (2017) · Journal of Epidemiology · doi:10.1016/j.je.2016.10.002 · Cited by 47
IL-6: A Potential Role in Cardiac Metabolic Homeostasis
Xu, Y., Zhang, Y., & Ye, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092474 · Cited by 44
Metabolic Syndrome: An Evolving Clinical Construct
Vassallo, P., Driver, S. L., & Stone, N. J. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.07.012 · Cited by 42
Dai, Y., He, H., Li, S., Yang, L., Wang, X., Liu, Z., & An, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.622589 · Cited by 42
Physical Activity and Risk of Metabolic Phenotypes of Obesity
Martínez‐Gómez, D., Ortega, F. B., Hamer, M., López‐García, E., Struijk, E. A., Sadarangani, K. P., Lavie, C. J., & Rodríguez‐Artalejo, F. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.04.042 · Cited by 41
The Inflammasomes in Cardiovascular Disease
van Hout, G. P. J., & Bosch, L. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_2 · Cited by 35
Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation?
Moris, W., Verhaegh, P. L. M., Jonkers, D. M. A. E., van Deursen, C. T. B. M., & Koek, G. H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1693114 · Cited by 34
Kawamoto, R., Akase, T., Ninomiya, D., Kumagi, T., & Kikuchi, A. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02320-0 · Cited by 33
Cocoa Flavanols Protect Human Endothelial Cells from Oxidative Stress
Martins, T. F., Palomino, O. M., Álvarez‐Cilleros, D., Martín, M. Á., Ramos, S., & Goya, L. (2020) · Plant Foods for Human Nutrition · doi:10.1007/s11130-020-00807-1 · Cited by 33
Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
Babiker, A., Hassan, M. S., Muhammed, S., Taylor, G. H., Poonia, B., Shah, A. S. V., & Bagchi, S. (2019) · Clinical Cardiology · doi:10.1002/clc.23299 · Cited by 32
The Cardiovascular effects of chocolate
Garcia, J. P., Santana, A., Baruqui, D. L., & Suraci, N. (2018) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2018.04.3187 · Cited by 28
Mayer, O., Gelžinský, J., Seidlerová, J., Mateřánková, M., Mareš, Š., Svobodová, V., Trefil, L., Cífková, R., & Filipovský, J. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-0327-3 · Cited by 27
Ikawa, M., Okazawa, H., & Yoneda, M. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129832 · Cited by 25
Ferrière, A., Santa, P., Garreau, A., Bandopadhyay, P., Blanco, P., Ganguly, D., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624256 · Cited by 24
Brain mechanisms of stress and depression in coronary artery disease
Bremner, J. D., Campanella, C., Khan, Z., Fani, N., Kasher, N., Evans, S., Reiff, C. M., Mishra, S., Ladd, S. L., Nye, J. A., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.11.017 · Cited by 19
Associations between IL-6 and Echo-Parameters in Patients with Early Onset Coronary Artery Disease
Pauli, N., Puchałowicz, K., Kuligowska, A., Krzystolik, A., Dziedziejko, V., Safranow, K., Rać, M., Chlubek, D., & Rać, M. E. (2019) · Diagnostics · doi:10.3390/diagnostics9040189 · Cited by 19
The Importance of Cellular Senescence in Frailty and Cardiovascular Diseases
Boccardi, V., & Mecocci, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-33330-0_9 · Cited by 19
Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases
Kigawa, Y., Miyazaki, T., Lei, X., Kim‐Kaneyama, J., & Miyazaki, A. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33431 · Cited by 18
Cardiovascular Comorbidities in Psoriatic Disease
Szentpétery, Á., Haroon, M., & FitzGerald, O. (2019) · Rheumatology and Therapy · doi:10.1007/s40744-019-00185-4 · Cited by 18
Osteocalcin and sclerostin: Background characters or main actors in cardiovascular disease?
D’Onofrio, L., Maddaloni, E., & Buzzetti, R. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3217 · Cited by 17
Toulassi, I. A., Saedi, U. A. A., Gutlapalli, S. D., Poudel, S., Kondapaneni, V., Zeb, M., & Cancarevic, I. (2021) · Cureus · doi:10.7759/cureus.12735 · Cited by 16
Folsom, A. R., Lutsey, P. L., Heckbert, S. R., Poudel, K., Basu, S., Hoogeveen, R. C., Cushman, M., & Ballantyne, C. M. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14241 · Cited by 14
Molecular Scavengers, Oxidative Stress and Cardiovascular Disease
Minno, A. D., Stornaiuolo, M., & Novellino, E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111895 · Cited by 13
Night work is related to higher global and central adiposity in Brazil: National Health Survey, 2013
Correia, F. G. S., Ferreira, M. J. M., Giatti, L., Camelo, L. D. V., & Araújo, L. F. (2019) · American Journal of Industrial Medicine · doi:10.1002/ajim.23054 · Cited by 11
Kobori, T., Ganesh, D., Kumano-Kuramochi, M., Torigoe, K., & Machida, S. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114018 · Cited by 10
Kim, H.-J., Kim, H., Kim, H., Yoo, Y., & Song, B. J. (2019) · Journal of Nursing Research · doi:10.1097/jnr.0000000000000345 · Cited by 5
Cited by
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Metabolic syndrome-related kidney injury: a review and update
Lin, L., Tan, W., Pan, X., Tian, E., Wu, Z., & Yang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.904001 · Cited by 139
Direito, R., Barbalho, S. M., Figueira, M. E., Minniti, G., de Carvalho, G. M., de Oliveira Zanuso, B., de Oliveira dos Santos, A. R., de Góes Corrêa, N., Rodrigues, V. D., de Alvares Goulart, R., et al. (2023) · Metabolites · doi:10.3390/metabo13060728 · Cited by 32
Self-citation
Metadata
- Authors
- Silveira Rossi, J. L., Barbalho, S. M., Reverete de Araujo, R., Bechara, M. D., Sloan, K. P., & Sloan, L. A.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2021-10-15
- Volume
- 38
- Issue
- 3
- Pages
- e3502-e3502
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W3204875794
- Cited by
- 604
- References
- 99
- FWCI
- 49.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.